Supplementary information for pharmaceutical wholesalers on the Windsor Framework

Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.

Supplementary information for pharmaceutical wholesalers on the Windsor Framework

Details

The Windsor Framework introduces a UK-wide licensing regime, meaning that the same medicinal products, in the same packs with the same packaging will be available across the whole UK. The Medicines and Healthcare products Regulatory Agency (MHRA) will license all medicines across the UK, including novel medicines, which under the original Protocol had to be authorised for Northern Ireland by the European Commission.

This information is designed to help wholesalers understand the main changes that have been introduced by the Windsor Framework's medicines arrangements which came into effect on 1 January 2025.